• OPEN AN ACCOUNT
Indian Indices
Sensex
73,598.67 -8.08
( -0.01%)
Global Indices
Nasdaq
52,406.83 24.25
(0.05%)
Dow Jones
7,744.04 46.27
(0.60%)
Hang Seng
63,411.54 1,221.89
(1.96%)
Nikkei 225
10,685.39 -81.94
(-0.76%)
Forex
USD-INR
94.93 0.33
(0.34%)
EUR-INR
106.36 0.18
(0.17%)
GBP-INR
126.93 0.23
(0.18%)
JPY-INR
0.61 0.00
(0.53%)

BSE Announcement

EQUITY - MARKET SCREENER

AAVAS Financiers Ltd

Aavas Financiers Limited has informed the Exchange about Copies of Newspaper Clippings of Unaudited Financial Results for the Quarter and Half Year ended September 30, 2026
ACC Ltd
ACC Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "ACC Builds Momentum with Improved Trade Mix, Capacity Expansion and Progress on One Cement Platform".
Acutaas Chemicals Ltd

Acutaas Chemicals Limited has informed the Exchange about Investor Presentation
Aditya Birla Money Ltd
Aditya Birla Money Limited has informed the Exchange about Copy of Newspaper Publication
Aditya Birla Real Estate Ltd

Aditya Birla Real Estate Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results for the quarter ended 30th September, 2026.
Aditya Birla Sun Life AMC Ltd
Aditya Birla Sun Life AMC Limited has informed the Exchange about Transcript of Earnings Conference Call on Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026
Aditya Infotech Ltd

Aditya Infotech Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "Ranveer Singh Joins CP PLUS as Brand Ambassador, India s Leading Brand in Smart Security Revolution".
Aequs Ltd
Submission of copies of newspaper publications regarding the statement of Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30, 2026
Akshar Spintex Ltd

Akshar Spintex Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.
Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Limited receives USFDA Final Approval for Valganciclovir for Oral Solution, 50 mg/mL.
<< < 1 2 3  ... > >>